[go: up one dir, main page]

AU2001278319A1 - Amyloid targeting imaging agents and uses thereof - Google Patents

Amyloid targeting imaging agents and uses thereof

Info

Publication number
AU2001278319A1
AU2001278319A1 AU2001278319A AU7831901A AU2001278319A1 AU 2001278319 A1 AU2001278319 A1 AU 2001278319A1 AU 2001278319 A AU2001278319 A AU 2001278319A AU 7831901 A AU7831901 A AU 7831901A AU 2001278319 A1 AU2001278319 A1 AU 2001278319A1
Authority
AU
Australia
Prior art keywords
imaging agents
targeting imaging
amyloid targeting
amyloid
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278319A
Inventor
Robert Chalifour
Francine Gervais
Xianqi Kong
David Migneault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bellus Health Inc
Original Assignee
Neurochem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurochem Inc filed Critical Neurochem Inc
Publication of AU2001278319A1 publication Critical patent/AU2001278319A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001278319A 2000-07-25 2001-07-25 Amyloid targeting imaging agents and uses thereof Abandoned AU2001278319A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22080800P 2000-07-25 2000-07-25
US60/220,808 2000-07-25
US09/915,092 US20020115717A1 (en) 2000-07-25 2001-07-24 Amyloid targeting imaging agents and uses thereof
US09/915,092 2001-07-24
PCT/CA2001/001071 WO2002007781A2 (en) 2000-07-25 2001-07-25 Amyloid targeting imaging agents and uses thereof

Publications (1)

Publication Number Publication Date
AU2001278319A1 true AU2001278319A1 (en) 2002-02-05

Family

ID=26915211

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278319A Abandoned AU2001278319A1 (en) 2000-07-25 2001-07-25 Amyloid targeting imaging agents and uses thereof

Country Status (6)

Country Link
US (1) US20020115717A1 (en)
EP (1) EP1303311A2 (en)
AU (1) AU2001278319A1 (en)
CA (1) CA2416617A1 (en)
NO (1) NO20030397L (en)
WO (1) WO2002007781A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2375628A1 (en) * 1999-07-09 2001-01-18 Isis Innovation Limited Compounds for inhibiting diseases and preparing cells for transplantation
WO2002064084A2 (en) * 2000-11-02 2002-08-22 Cornell Research Foundation, Inc. In vivo multiphoton diagnostic detection and imaging of a neurodegenerative disease
US20040049134A1 (en) * 2002-07-02 2004-03-11 Tosaya Carol A. System and methods for treatment of alzheimer's and other deposition-related disorders of the brain
DE10230141B4 (en) * 2002-07-04 2004-07-15 Priontype Gmbh Method and kit for the enrichment and detection of modified prion proteins (PrPSc)
RU2005126421A (en) * 2003-01-22 2006-02-10 Дзе Дженерал Хоспитал Корпорейшн (Us) AMYLO-BINDING METAL-CHELATING AGENTS
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
WO2004113277A2 (en) * 2003-06-23 2004-12-29 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20050214222A1 (en) * 2004-02-13 2005-09-29 Mckinnon Stuart J In vivo imaging of amyloid plaques in glaucoma using intravenous injectable dyes
US7803351B2 (en) * 2004-08-20 2010-09-28 Washington University Blood brain barrier permeation peptides
AU2005310986A1 (en) * 2004-11-12 2006-06-08 Bellus Health (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
JP5145537B2 (en) * 2004-12-22 2013-02-20 ビーエイチアイ リミテッド パートナーシップ Methods and compositions for treating amyloid-related diseases
US9335331B2 (en) * 2005-04-11 2016-05-10 Cornell Research Foundation, Inc. Multiplexed biomarkers for monitoring the Alzheimer's disease state of a subject
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
US20070049638A1 (en) * 2005-07-21 2007-03-01 Neurochem (International) Limited Polymorphic forms of 3-amino-1-propanesulfonic acid
ATE481094T1 (en) * 2005-12-22 2010-10-15 Kiacta Sarl TREATMENT OF DIABETIC NEPHROPATHY
ES2967330T3 (en) 2006-10-12 2024-04-29 Bellus Health Inc Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
JP2010529947A (en) * 2006-12-22 2010-09-02 ベラス ヘルス（インターナショナル）リミテッド Methods, compounds, and compositions for treating metabolic diseases and diabetes
JP2011512354A (en) 2008-02-14 2011-04-21 シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド A novel contrast agent for detecting neurological dysfunction
WO2010087315A1 (en) * 2009-01-29 2010-08-05 株式会社林原生物化学研究所 Anti-alzheimer’s disease agent
EP2397139B1 (en) * 2009-01-29 2014-09-17 Hayashibara Co., Ltd. Anti-neurodegenerative disease agent
JPWO2010087313A1 (en) * 2009-01-29 2012-08-02 株式会社林原生物化学研究所 Neurite outgrowth promoter
US9023767B2 (en) * 2009-05-07 2015-05-05 Memorial Sloan-Kettering Cancer Center γ-Secretase substrates and methods of use
US9632088B2 (en) 2010-09-07 2017-04-25 Memorial Sloan-Kettering Cancer Center Methods and compositions for gamma-secretase assay
US9683017B2 (en) 2014-07-17 2017-06-20 University Tennessee Research Foundation Inhibitory peptides of viral infection
WO2016032949A1 (en) * 2014-08-26 2016-03-03 University Of Tennessee Research Foundation Targeting immunotherapy for amyloidosis
US10493172B2 (en) 2016-06-02 2019-12-03 California Institute Of Technology Gas-filled structures and related compositions, methods and systems to image a target site
US11118210B2 (en) 2016-07-28 2021-09-14 California Institute Of Technology Genetically engineered gas vesicle gene clusters, genetic circuits, vectors, prokaryotic cells, compositions, methods and systems for contrast-enhanced imaging
WO2020146379A1 (en) 2019-01-07 2020-07-16 California Institute Of Technology Gas vesicle expression systems, gas vesicle constructs and related genetic circuits, vectors, mammalian cells, hosts, compositions, methods and systems
WO2020146367A1 (en) 2019-01-07 2020-07-16 California Institute Of Technology Burst ultrasound reconstruction with signal templates and related methods and systems
WO2020198728A1 (en) * 2019-03-28 2020-10-01 California Institute Of Technology Compositions, methods and systems for gas vesicle based cavitation
CN111398465B (en) * 2020-04-03 2021-08-10 北京先通国际医药科技股份有限公司 Method for measuring precursor FCPHA of PET imaging agent and cis-isomer thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840294A (en) * 1993-03-29 1998-11-24 Queen's University At Kingston Method for treating amyloidosis
US6054114A (en) * 1996-05-08 2000-04-25 Massachusetts Institute Of Technology Organometallic ligands for the localization and quantification of amyloid in vivo and in vitro
US6261537B1 (en) * 1996-10-28 2001-07-17 Nycomed Imaging As Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors
WO2001039796A2 (en) * 1999-11-29 2001-06-07 Neurochem Inc. Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
WO2001087354A2 (en) * 2000-05-17 2001-11-22 Bristol-Myers Squibb Pharma Company Use of small molecule radioligands for diagnostic imaging
US6589504B1 (en) * 2000-09-22 2003-07-08 Pharmacia & Upjohn Company Compounds and methods for diagnosing and treating amyloid-related conditions

Also Published As

Publication number Publication date
NO20030397D0 (en) 2003-01-24
NO20030397L (en) 2003-03-24
US20020115717A1 (en) 2002-08-22
WO2002007781A3 (en) 2002-10-31
EP1303311A2 (en) 2003-04-23
CA2416617A1 (en) 2002-01-31
WO2002007781A2 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
AU2001278319A1 (en) Amyloid targeting imaging agents and uses thereof
AU2002245629A1 (en) Stabilized therapeutic and imaging agents
AU2001246803A1 (en) An image sensor and an endoscope using the same
AU2001287299A1 (en) Benzoylpyrazols and their use as herbicides
AU2001265008A1 (en) Caspase inhibitors and uses thereof
AU8729901A (en) Benzoylpyrazols and their use as herbicides
AU2001288040A1 (en) Homeostasis-maintaining agents
AU2001284662A1 (en) Toric-shaped lenses and goggle assembly
AU2002214284A1 (en) Anti-helicobacterial agents
GB2358903B (en) Yoke and shaft connection
AU2002236639A1 (en) Indirect mode imaging
AU2001277526A1 (en) Substituted benzo-nitro-heterocycles and use thereof as herbicides
AU2001289308A1 (en) Targeted agents useful for diagnostic and therapeutic applications
AU2002221381A1 (en) Imaging device
AU2002211717A1 (en) Stresscopins and their uses
AU2002210916A1 (en) Endoscope attachment and endoscope
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001273903A1 (en) Therapeutic agents
AU2002234165A1 (en) Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
AU4432001A (en) Trityl-type compounds and their use
AU2001274309A1 (en) Phosphoglycan messengers and their medical uses
AU2001291962A1 (en) Angiogenic agents and their uses
AU2001277519A1 (en) Bio-probes and use thereof